Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea
· Delayed Price · Currency is KRW 9,320.00
-10.00 (-0.11%)
Feb 21, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 214.30 billion as of February 21, 2025. Its market cap has decreased by -54.09% in one year.
Market Cap
214.30B
Enterprise Value
167.45B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,320.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 214.30B, an increase of 33.73%. That is a compound annual growth rate of 6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 214.30B | -10.64% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 384.51T |
| SK hynix | 144.35T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 82.35T |
| Hyundai Motor Company | 45.50T |
| Celltrion | 37.80T |
| Kia Corporation | 36.86T |
| NAVER | 34.26T |